BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
BRCA1
,
T cell receptor signaling pathway
,
Diabetes mellitus
,
Heart
,
Amniocentesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Chk-2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Superior cervical ganglion
Olfactory bulb
Smooth muscle
Appendix
Ciliary ganglion
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
CHEK2 signaling is the key regulator of oocyte survival after chemotherapy.
CHEK2 deficiency increase the response to PD-1 inhibitors by affecting the tumor immune microenviron…
Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 va…
Rad53 regulates the lifetime of Rdh54 at homologous recombination intermediates.
MiR-669b-5p inhibits the Alzheimer's disease development via regulation of CHEK2 in Neuro2a APPSwe/Δ…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CHK-336 in Healthy Volunteers
A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated…
Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer
A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Nec…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ